Skip to main content
Erschienen in: Endocrine 1/2017

31.03.2016 | Original Article

Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism

verfasst von: Giuseppe Viccica, Filomena Cetani, Edda Vignali, Mario Miccoli, Claudio Marcocci

Erschienen in: Endocrine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the study was to evaluate the relationship between serum 25(OH)D and the clinical phenotype in 215 consecutive Italian Caucasian women with sporadic primary hyperparathyroidism (PHPT) not taking vitamin D supplements. The study was performed at a single Italian tertiary center. PHPT-related manifestations, serum 25(OH)D, and other parameters of calcium metabolism and bone mineral density (BMD) by DXA were recorded. Serum 25(OH)D was negatively correlated with age (r = −0.18; P = 0.006), BMI (r = −0.20; P = 0.002), PTH (r = −0.21; P = 0.001), bone-specific alkaline phosphatase (BSAP) (r = −0.27; P < 0.001), and eGFR (r = −0.22; P = 0.01), and positively with serum creatinine and 1/3 distal radius BMD (R-BMD; r = 0.17; P = 0.015). In a multivariate regression analysis, serum 25(OH)D remained significantly correlated with age (r = −0.18; P = 0.005), BMI (r = −0.23; P = 0.049), serum PTH (r = −0.01; P = 0.023), BSAP (r = −0.01; P = 0.023) and eGFR (r = −0.09; P = 0.001), but not with R-BMD. Serum 25(OHD) was higher in patients with nephrolithiasis than in those without nephrolithiasis (18.5 ± 8.8 vs. 15.6 ± 8.0 ng/ml; P = 0.029), whereas no difference was found between fractured and unfractured patients (16.8 ± 9.3 vs. 16.0 ± 7.7; P = 0.663). There was a statistically significant inverse correlation between vitamin D status [defined by quartiles of measured values as well as commonly accepted cutoffs of serum 25(OH)D] and severity of the disease, as reflected by higher PTH and BSAP, but not by meeting the latest guidelines for parathyroidectomy. In conclusion, a low vitamin D status is associated with some features reflecting a more severe biochemical and clinical phenotype of PHPT in Italian women not taking vitamin D supplements.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat E. Nordenstrom, A. Sitges-Serra, J.J. Sancho, M. Thier, M. Almquist, Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from Southern and Northern Europe. Int. J. Endocrinol. 2013, 164939 (2013). doi:10.1155/2013/164939 CrossRefPubMedPubMedCentral E. Nordenstrom, A. Sitges-Serra, J.J. Sancho, M. Thier, M. Almquist, Vitamin d status in patients operated for primary hyperparathyroidism: comparison of patients from Southern and Northern Europe. Int. J. Endocrinol. 2013, 164939 (2013). doi:10.​1155/​2013/​164939 CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat J.M. Liu, N.E. Cusano, B.C. Silva, L. Zhao, X.Y. He, B. Tao, L.H. Sun, H.Y. Zhao, W.W. Fan, M.E. Romano, G. Ning, J.P. Bilezikian, Primary hyperparathyroidism: a tale of two cities revisited—New York and Shanghai. Bone. Res. 1(2), 162–169 (2013). doi:10.4248/BR201302005 CrossRefPubMedPubMedCentral J.M. Liu, N.E. Cusano, B.C. Silva, L. Zhao, X.Y. He, B. Tao, L.H. Sun, H.Y. Zhao, W.W. Fan, M.E. Romano, G. Ning, J.P. Bilezikian, Primary hyperparathyroidism: a tale of two cities revisited—New York and Shanghai. Bone. Res. 1(2), 162–169 (2013). doi:10.​4248/​BR201302005 CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat S. Varshney, S.K. Bhadada, U.N. Saikia, N. Sachdeva, A. Behera, A.K. Arya, S. Sharma, A. Bhansali, A. Mithal, S.D. Rao, Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians. Eur. J. Endocrinol. 169(1), 109–116 (2013). doi:10.1530/EJE-13-0085 CrossRefPubMed S. Varshney, S.K. Bhadada, U.N. Saikia, N. Sachdeva, A. Behera, A.K. Arya, S. Sharma, A. Bhansali, A. Mithal, S.D. Rao, Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians. Eur. J. Endocrinol. 169(1), 109–116 (2013). doi:10.​1530/​EJE-13-0085 CrossRefPubMed
6.
Zurück zum Zitat A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J. Am. Diet. Assoc. 111(4), 524–527 (2011). doi:10.1016/j.jada.2011.01.004 CrossRefPubMed A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 dietary reference intakes for calcium and vitamin D: what dietetics practitioners need to know. J. Am. Diet. Assoc. 111(4), 524–527 (2011). doi:10.​1016/​j.​jada.​2011.​01.​004 CrossRefPubMed
7.
Zurück zum Zitat C. Marcocci, J. Bollerslev, A.A. Khan, D.M. Shoback, Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(10), 3607–3618 (2014). doi:10.1210/jc.2014-1417 CrossRefPubMed C. Marcocci, J. Bollerslev, A.A. Khan, D.M. Shoback, Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(10), 3607–3618 (2014). doi:10.​1210/​jc.​2014-1417 CrossRefPubMed
9.
Zurück zum Zitat D.S. Rao, M. Honasoge, G.W. Divine, E.R. Phillips, M.W. Lee, M.R. Ansari, G.B. Talpos, A.M. Parfitt, Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J. Clin. Endocrinol. Metab. 85(3), 1054–1058 (2000). doi:10.1210/jcem.85.3.6440 PubMed D.S. Rao, M. Honasoge, G.W. Divine, E.R. Phillips, M.W. Lee, M.R. Ansari, G.B. Talpos, A.M. Parfitt, Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J. Clin. Endocrinol. Metab. 85(3), 1054–1058 (2000). doi:10.​1210/​jcem.​85.​3.​6440 PubMed
10.
Zurück zum Zitat B. Moosgaard, P. Vestergaard, L. Heickendorff, F. Melsen, P. Christiansen, L. Mosekilde, Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin. Endocrinol. 63(5), 506–513 (2005). doi:10.1111/j.1365-2265.2005.02371.x CrossRef B. Moosgaard, P. Vestergaard, L. Heickendorff, F. Melsen, P. Christiansen, L. Mosekilde, Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin. Endocrinol. 63(5), 506–513 (2005). doi:10.​1111/​j.​1365-2265.​2005.​02371.​x CrossRef
11.
Zurück zum Zitat P. Boudou, F. Ibrahim, C. Cormier, E. Sarfati, J.C. Souberbielle, A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J. Endocrinol. Invest. 29(6), 511–515 (2006). doi:10.1007/BF03344140 CrossRefPubMed P. Boudou, F. Ibrahim, C. Cormier, E. Sarfati, J.C. Souberbielle, A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism. J. Endocrinol. Invest. 29(6), 511–515 (2006). doi:10.​1007/​BF03344140 CrossRefPubMed
12.
Zurück zum Zitat S.J. Silverberg, E. Shane, D.W. Dempster, J.P. Bilezikian, The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am. J. Med. 107(6), 561–567 (1999)CrossRefPubMed S.J. Silverberg, E. Shane, D.W. Dempster, J.P. Bilezikian, The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am. J. Med. 107(6), 561–567 (1999)CrossRefPubMed
15.
Zurück zum Zitat M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, S. Endocrine, Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7), 1911–1930 (2011). doi:10.1210/jc.2011-0385 CrossRefPubMed M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, S. Endocrine, Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7), 1911–1930 (2011). doi:10.​1210/​jc.​2011-0385 CrossRefPubMed
16.
Zurück zum Zitat J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014). doi:10.1210/jc.2014-1413 CrossRefPubMed J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014). doi:10.​1210/​jc.​2014-1413 CrossRefPubMed
17.
Zurück zum Zitat M.D. Walker, E. Cong, J.A. Lee, A. Kepley, C. Zhang, D.J. McMahon, S.J. Silverberg, Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J. Clin. Endocrinol. Metab. 100(9), 3443–3451 (2015). doi:10.1210/jc.2015-2022 CrossRefPubMedPubMedCentral M.D. Walker, E. Cong, J.A. Lee, A. Kepley, C. Zhang, D.J. McMahon, S.J. Silverberg, Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J. Clin. Endocrinol. Metab. 100(9), 3443–3451 (2015). doi:10.​1210/​jc.​2015-2022 CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat F. Cetani, E. Pardi, S. Borsari, M. Tonacchera, E. Morabito, A. Pinchera, C. Marcocci, G. Dipollina, Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation. Clin. Endocrinol. 58(2), 199–206 (2003)CrossRef F. Cetani, E. Pardi, S. Borsari, M. Tonacchera, E. Morabito, A. Pinchera, C. Marcocci, G. Dipollina, Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation. Clin. Endocrinol. 58(2), 199–206 (2003)CrossRef
19.
Zurück zum Zitat A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal Disease study group. Ann. Intern. Med. 130(6), 461–470 (1999)CrossRefPubMed A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal Disease study group. Ann. Intern. Med. 130(6), 461–470 (1999)CrossRefPubMed
20.
Zurück zum Zitat E.M. Lewiecki, C.M. Gordon, S. Baim, M.B. Leonard, N.J. Bishop, M.L. Bianchi, H.J. Kalkwarf, C.B. Langman, H. Plotkin, F. Rauch, B.S. Zemel, N. Binkley, J.P. Bilezikian, D.L. Kendler, D.B. Hans, S. Silverman, International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone. 43(6), 1115–1121 (2008). doi:10.1016/j.bone.2008.08.106 CrossRefPubMed E.M. Lewiecki, C.M. Gordon, S. Baim, M.B. Leonard, N.J. Bishop, M.L. Bianchi, H.J. Kalkwarf, C.B. Langman, H. Plotkin, F. Rauch, B.S. Zemel, N. Binkley, J.P. Bilezikian, D.L. Kendler, D.B. Hans, S. Silverman, International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone. 43(6), 1115–1121 (2008). doi:10.​1016/​j.​bone.​2008.​08.​106 CrossRefPubMed
21.
Zurück zum Zitat E. Vignali, G. Viccica, D. Diacinti, F. Cetani, L. Cianferotti, E. Ambrogini, C. Banti, R. Del Fiacco, J.P. Bilezikian, A. Pinchera, C. Marcocci, Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94(7), 2306–2312 (2009). doi:10.1210/jc.2008-2006 CrossRefPubMedPubMedCentral E. Vignali, G. Viccica, D. Diacinti, F. Cetani, L. Cianferotti, E. Ambrogini, C. Banti, R. Del Fiacco, J.P. Bilezikian, A. Pinchera, C. Marcocci, Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 94(7), 2306–2312 (2009). doi:10.​1210/​jc.​2008-2006 CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat M. Peacock, Primary hyperparathyroidism and the kidney. The parathyroids. Basic and clinical concepts. (Elsevier Inc., London, 2015) M. Peacock, Primary hyperparathyroidism and the kidney. The parathyroids. Basic and clinical concepts. (Elsevier Inc., London, 2015)
25.
Zurück zum Zitat A. D’Angelo, M.G. Lodetti, S. Giannini, R. Castrignano, M. Al Awady, L. Malvasi, A. Fabris, G. Maschio, Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis? Miner. Electrolyte. Metab. 18(6), 359–364 (1992)PubMed A. D’Angelo, M.G. Lodetti, S. Giannini, R. Castrignano, M. Al Awady, L. Malvasi, A. Fabris, G. Maschio, Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis? Miner. Electrolyte. Metab. 18(6), 359–364 (1992)PubMed
26.
Zurück zum Zitat C.V. Odvina, K. Sakhaee, H.J. Heller, R.D. Peterson, J.R. Poindexter, P.K. Padalino, C.Y. Pak, Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol. Res. 35(3), 123–128 (2007). doi:10.1007/s00240-007-0096-2 CrossRefPubMed C.V. Odvina, K. Sakhaee, H.J. Heller, R.D. Peterson, J.R. Poindexter, P.K. Padalino, C.Y. Pak, Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol. Res. 35(3), 123–128 (2007). doi:10.​1007/​s00240-007-0096-2 CrossRefPubMed
27.
Zurück zum Zitat S.J. Silverberg, E. Shane, T.P. Jacobs, E.S. Siris, F. Gartenberg, D. Seldin, T.L. Clemens, J.P. Bilezikian, Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am. J. Med. 89(3), 327–334 (1990)CrossRefPubMed S.J. Silverberg, E. Shane, T.P. Jacobs, E.S. Siris, F. Gartenberg, D. Seldin, T.L. Clemens, J.P. Bilezikian, Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am. J. Med. 89(3), 327–334 (1990)CrossRefPubMed
28.
Zurück zum Zitat F. Tassone, L. Gianotti, C. Baffoni, G. Visconti, M. Pellegrino, S. Cassibba, C.G. Croce, G. Magro, F. Cesario, R. Attanasio, G. Borretta, Vitamin D status in primary hyperparathyroidism: a Southern European perspective. Clin. Endocrinol. 79(6), 784–790 (2013). doi:10.1111/cen.12210 CrossRef F. Tassone, L. Gianotti, C. Baffoni, G. Visconti, M. Pellegrino, S. Cassibba, C.G. Croce, G. Magro, F. Cesario, R. Attanasio, G. Borretta, Vitamin D status in primary hyperparathyroidism: a Southern European perspective. Clin. Endocrinol. 79(6), 784–790 (2013). doi:10.​1111/​cen.​12210 CrossRef
29.
Zurück zum Zitat V. Carnevale, G. Manfredi, E. Romagnoli, S. De Geronimo, F. Paglia, J. Pepe, A. Scillitani, E. D’Erasmo, S. Minisola, Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin. Endocrinol. 60(1), 81–86 (2004)CrossRef V. Carnevale, G. Manfredi, E. Romagnoli, S. De Geronimo, F. Paglia, J. Pepe, A. Scillitani, E. D’Erasmo, S. Minisola, Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin. Endocrinol. 60(1), 81–86 (2004)CrossRef
31.
Zurück zum Zitat B. Moosgaard, P. Vestergaard, L. Heickendorff, F. Melsen, P. Christiansen, L. Mosekilde, Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol. 155(2), 237–244 (2006). doi:10.1530/eje.1.02197 CrossRefPubMed B. Moosgaard, P. Vestergaard, L. Heickendorff, F. Melsen, P. Christiansen, L. Mosekilde, Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol. 155(2), 237–244 (2006). doi:10.​1530/​eje.​1.​02197 CrossRefPubMed
32.
Zurück zum Zitat H. Raef, S. Ingemansson, S. Sobhi, A. Sultan, M. Ahmed, M. Chaudhry, The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region. J. Endocrinol. Invest. 27(9), 807–812 (2004). doi:10.1007/BF03346273 CrossRefPubMed H. Raef, S. Ingemansson, S. Sobhi, A. Sultan, M. Ahmed, M. Chaudhry, The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region. J. Endocrinol. Invest. 27(9), 807–812 (2004). doi:10.​1007/​BF03346273 CrossRefPubMed
33.
Zurück zum Zitat N. Ozbey, Y. Erbil, E. Ademoglu, S. Ozarmagan, U. Barbaros, A. Bozbora, Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World. J. Surg. 30(3), 321–326 (2006). doi:10.1007/s00268-005-0239-y CrossRefPubMed N. Ozbey, Y. Erbil, E. Ademoglu, S. Ozarmagan, U. Barbaros, A. Bozbora, Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World. J. Surg. 30(3), 321–326 (2006). doi:10.​1007/​s00268-005-0239-y CrossRefPubMed
34.
35.
36.
Zurück zum Zitat Y. Inoue, H. Kaji, I. Hisa, T. Tobimatsu, J. Naito, M.F. Iu, T. Sugimoto, K. Chihara, Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism. Endocr. J. 55(1), 57–65 (2008)CrossRefPubMed Y. Inoue, H. Kaji, I. Hisa, T. Tobimatsu, J. Naito, M.F. Iu, T. Sugimoto, K. Chihara, Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism. Endocr. J. 55(1), 57–65 (2008)CrossRefPubMed
37.
Zurück zum Zitat D.S. Rao, G. Agarwal, G.B. Talpos, E.R. Phillips, F. Bandeira, S.K. Mishra, A. Mithal, Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J. Bone. Miner. Res. 17(Suppl 2), N75–80 (2002)PubMed D.S. Rao, G. Agarwal, G.B. Talpos, E.R. Phillips, F. Bandeira, S.K. Mishra, A. Mithal, Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J. Bone. Miner. Res. 17(Suppl 2), N75–80 (2002)PubMed
38.
Zurück zum Zitat P. Farahnak, G. Larfars, M. Sten-&&&&&&&Linder, I.L. Nilsson, Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J. Clin. Endocrinol. Metab. 96(7), 2112–2118 (2011). doi:10.1210/jc.2011-0238 CrossRefPubMed P. Farahnak, G. Larfars, M. Sten-&&&&&&&Linder, I.L. Nilsson, Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J. Clin. Endocrinol. Metab. 96(7), 2112–2118 (2011). doi:10.​1210/​jc.​2011-0238 CrossRefPubMed
39.
Zurück zum Zitat A. Grey, J. Lucas, A. Horne, G. Gamble, J.S. Davidson, I.R. Reid, Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J. Clin. Endocrinol. Metab. 90(4), 2122–2126 (2005). doi:10.1210/jc.2004-1772 CrossRefPubMed A. Grey, J. Lucas, A. Horne, G. Gamble, J.S. Davidson, I.R. Reid, Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J. Clin. Endocrinol. Metab. 90(4), 2122–2126 (2005). doi:10.​1210/​jc.​2004-1772 CrossRefPubMed
40.
42.
Zurück zum Zitat L. Rolighed, L. Rejnmark, T. Sikjaer, L. Heickendorff, P. Vestergaard, L. Mosekilde, P. Christiansen, Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab. 99(3), 1072–1080 (2014). doi:10.1210/jc.2013-3978 CrossRefPubMed L. Rolighed, L. Rejnmark, T. Sikjaer, L. Heickendorff, P. Vestergaard, L. Mosekilde, P. Christiansen, Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. J. Clin. Endocrinol. Metab. 99(3), 1072–1080 (2014). doi:10.​1210/​jc.​2013-3978 CrossRefPubMed
Metadaten
Titel
Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism
verfasst von
Giuseppe Viccica
Filomena Cetani
Edda Vignali
Mario Miccoli
Claudio Marcocci
Publikationsdatum
31.03.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0931-8

Weitere Artikel der Ausgabe 1/2017

Endocrine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.